Praphan Phanuphak Selected Research

Indinavir (Crixivan)

10/2012	Pharmacokinetics and 48 week efficacy of adjusted dose indinavir/ritonavir in rifampicin-treated HIV/tuberculosis-coinfected patients: a pilot study.
1/2011	Monoboosted lopinavir/ritonavir as simplified second-line maintenance therapy in virologically suppressed children.
6/2006	The use of pharmacokinetically guided indinavir dose reductions in the management of indinavir-associated renal toxicity.
4/2006	Maintenance of successful ritonavir-boosted indinavir and efavirenz therapy in an HIV-infected patient with tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Praphan Phanuphak Research Topics

Disease

30	HIV Infections (HIV Infection) 01/2022 - 06/2004
15	Infections 01/2022 - 09/2003
10	Coinfection 01/2021 - 10/2003
9	Acquired Immunodeficiency Syndrome (AIDS) 09/2020 - 06/2004
9	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2020 - 09/2003
8	Tuberculosis (Tuberculoses) 08/2014 - 01/2005
6	Disease Progression 02/2015 - 11/2003
5	Syphilis 01/2022 - 01/2018
4	Hepatitis B 01/2022 - 03/2013
4	Viremia 10/2021 - 06/2004
4	Body Weight (Weight, Body) 12/2013 - 11/2005
3	Hepatitis C 01/2022 - 01/2016
2	Inflammation (Inflammations) 10/2021 - 01/2020
2	Opportunistic Infections (Opportunistic Infection) 01/2016 - 01/2015
2	Lipodystrophy 07/2014 - 01/2013
2	Exanthema (Rash) 11/2007 - 01/2005
1	Virus Diseases (Viral Diseases) 01/2022
1	COVID-19 10/2021
1	HIV Seropositivity 01/2018
1	Insulin Resistance 11/2016
1	Hyperglycemia 08/2014
1	Drug-Related Side Effects and Adverse Reactions 12/2013
1	Clinical Deterioration 03/2013
1	Squamous Intraepithelial Lesions 01/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013
1	Chronic Renal Insufficiency 09/2012
1	Latent Tuberculosis 03/2012
1	Fowlpox 10/2010
1	Anemia 04/2009
1	Hypersensitivity (Allergy) 01/2008
1	Dyslipidemias (Dyslipidemia) 03/2007
1	Bites and Stings (Sting) 11/2006
1	Nephrolithiasis 06/2006
1	Pyuria 06/2006
1	Allergic Rhinitis 03/2005
1	Hepatitis 05/2004

Drug/Important Bio-Agent (IBA)

14	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2004
8	Pharmaceutical PreparationsIBA 01/2022 - 06/2004
7	NucleosidesIBA 01/2013 - 09/2003
6	Ritonavir (Norvir)FDA Link 01/2016 - 11/2005
6	Reverse Transcriptase InhibitorsIBA 01/2013 - 09/2003
5	N-acetyltalosaminuronic acid (NAT)IBA 09/2020 - 05/2004
5	Nucleic AcidsIBA 01/2019 - 10/2008
4	AntigensIBA 01/2022 - 03/2005
4	DNA (Deoxyribonucleic Acid)IBA 09/2020 - 10/2010
4	Amphetamine (Amfetamine)FDA LinkGeneric 01/2020 - 12/2017
4	VaccinesIBA 01/2019 - 10/2008
4	Indinavir (Crixivan)FDA Link 10/2012 - 04/2006
3	Biomarkers (Surrogate Marker)IBA 09/2020 - 01/2013
3	Raltegravir Potassium FDA Link 04/2018 - 01/2013
3	efavirenz (Sustiva)FDA Link 01/2016 - 01/2005
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2016 - 03/2007
3	Rifampin (Rifampicin)FDA LinkGeneric 10/2012 - 01/2005
3	Isoniazid (Ftivazide)FDA LinkGeneric 08/2012 - 02/2010
3	Nevirapine (Viramune)FDA Link 01/2008 - 01/2005
2	CreatinineIBA 01/2022 - 06/2006
2	Alanine Transaminase (SGPT)IBA 01/2022 - 01/2005
2	Antiviral Agents (Antivirals)IBA 01/2020 - 11/2012
2	EnzymesIBA 01/2019 - 10/2008
2	Tenofovir (Viread)FDA Link 01/2018 - 01/2016
2	Messenger RNA (mRNA)IBA 11/2016 - 01/2013
2	Lopinavir FDA Link 01/2016 - 01/2013
2	Atazanavir Sulfate (Reyataz)FDA Link 12/2013 - 12/2003
2	LipidsIBA 01/2013 - 03/2007
2	Tuberculin (PPD)IBA 08/2012 - 03/2012
2	Saquinavir (Invirase)FDA Link 01/2011 - 11/2005
2	Stavudine (Zerit)FDA LinkGeneric 03/2007 - 06/2004
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2005 - 09/2003
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022
1	Histone Deacetylase InhibitorsIBA 09/2020
1	Lipopolysaccharide ReceptorsIBA 09/2020
1	Interleukin-7 (Interleukin 7)IBA 09/2020
1	Vorinostat FDA Link 09/2020
1	Hemoglobins (Hemoglobin)IBA 09/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2020
1	Monoclonal AntibodiesIBA 01/2019
1	dolutegravirIBA 01/2019
1	Emtricitabine (Emtriva)FDA Link 01/2018
1	AntibodiesIBA 01/2016
1	Integrase InhibitorsIBA 01/2015
1	Maraviroc FDA Link 01/2015
1	CholesterolIBA 07/2014
1	TabletsIBA 01/2013
1	NucleotidesIBA 01/2013
1	lopinavir-ritonavir drug combination (Kaletra)FDA Link 01/2013
1	Cystatin CIBA 09/2012
1	Hormones (Hormone)IBA 04/2011
1	EpitopesIBA 01/2011
1	HLA-B57 antigenIBA 01/2011
1	apricitabineIBA 06/2006
1	HIV ProteaseIBA 03/2005

Therapy/Procedure

31	Therapeutics 01/2022 - 09/2003
14	Art Therapy 01/2022 - 01/2005
7	Highly Active Antiretroviral Therapy (HAART) 01/2016 - 05/2004
3	Condoms (Condom) 12/2017 - 11/2006
2	Ambulatory Care (Outpatient Care) 01/2021 - 01/2016
2	Aftercare (After-Treatment) 01/2015 - 03/2007
1	Long-Term Care 07/2014